Deakin University
Browse

File(s) not publicly available

Vasoconstriction with norepinephrine causes less forearm % resistance than a reflex sympathetic vasoconstriction

Version 2 2024-06-13, 14:45
Version 1 2021-10-20, 16:15
journal contribution
posted on 2024-06-13, 14:45 authored by KA Jamerson, SD Smith, JV Amerena, E Grant, S Julius
We used the insulin-perfused human forearm model to assess the effects of vasoconstriction induced with norepinephrine on the extraction of glucose in the forearm in two groups of healthy young volunteers. The norepinephrine findings were compared with a previously studied group in which vasoconstriction has been caused by reflex activation of the sympathetic nervous system. The aim of the study was to determine the relative importance of hemodynamic and receptor-mediated mechanisms of insulin resistance. Plasma insulin, arterial and venous glucose samples, and forearm blood flow were measured at 10-minute intervals during a 30-minute baseline, a 60-minute intra-arterial insulin infusion, and during 30 minutes of insulin infusion plus vasoconstriction. Group 1 (n = 14) had physiological vasoconstriction induced by inflation of bilateral thigh cuffs to 40 mm Hg to cause pooling of blood in the lower extremities and reflex vasoconstriction in the forearm; group 2 (n = 8) had intra-arterial infusion of norepinephrine to achieve the same degree of vasoconstriction as seen with inflation of thigh cuffs in group 1. Subjects in group 3 (n = 7) had infusion of intra-arterial norepinephrine to achieve a twofold increase in physiological vasoconstriction. With a physiological decrease in forearm blood flow (group 1), there was a 19% decrease in forearm blood flow resulting in a 23% reduction in glucose uptake in the forearm (P < .03). The same degree of reduction in forearm blood flow with a predominantly alpha-adrenergic agonist, norepinephrine (group 2), causes much less insulin resistance (a decrease in utilization of 13%) (P < .04).(ABSTRACT TRUNCATED AT 250 WORDS)

History

Journal

Hypertension

Volume

23

Pagination

1006-1016

Location

United States

ISSN

0194-911X

eISSN

1524-4563

Language

en

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

6

Publisher

Ovid Technologies (Wolters Kluwer Health)